Evidence map›Paper›PMID 40918468›Full record

ArticleOncology research2025

ERRγ Promotes Multiple Myeloma Survival by Coordinating NF-κB Signaling and Mitochondrial Apoptosis Regulation.

Xiaobing Zhou, Ying Li, Zizi Jing, Wei Yu, Jianbin Chen

Abstract read
In one paragraph

Article in Oncology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaobing ZhouDepartment of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Ying LiDepartment of Hematology, University-Town Hospital of Chongqing Medical University, Chongqing, 400016, China.
Zizi JingDepartment of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wei YuDepartment of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Jianbin ChenDepartment of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple myeloma (MM) remains a formidable clinical challenge due to its high relapse rate and resistance to existing therapies. Estrogen-related receptor gamma (ERRγ), a nuclear receptor critical for cellular energy metabolism, has been implicated in various cancers. but its role in MM remains unclear. Methods: ERRγ expression was assessed using bioinformatics and RT-qPCR. Functional studies were conducted through siRNA-mediated ERRγ knockdown and treatment with the inverse agonist GSK5182 to examine their effects on MM cell proliferation and apoptosis. Results: ERRγ was significantly upregulated in the bone marrow of MM patients, correlating with advanced clinical stages and pathological fractures. Inhibition of ERRγ reduced MM cell expansion both Conclusion: Collectively, the data broaden understanding of ERRγ's contribution to MM development and propose it as a viable target for therapeutic intervention.

Indexed as

ApoptosisMitochondriaMultiple MyelomaNF-kappa BReceptors, EstrogenAnimalsCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMiceSignal TransductionTamoxifenESRRG protein, humanGSK5182NF-kappa BReceptors, EstrogenTamoxifenapoptosisbone destructionestrogen-related receptor gamma (ERRγ)mitochondrial dysfunctionMultiple myeloma (MM)nuclear factor-kappa B (NF-κB)

Identifiers

PMID40918468
PMCPMC12408853

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.